nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—melanoma—meningioma	0.909	1	CtDrD
Docetaxel—MAP2—telencephalic ventricle—meningioma	0.00378	0.0937	CbGeAlD
Docetaxel—GHRHR—brainstem—meningioma	0.00332	0.0821	CbGeAlD
Docetaxel—GHRHR—cerebellum—meningioma	0.00164	0.0405	CbGeAlD
Docetaxel—GHRHR—brain—meningioma	0.00133	0.0329	CbGeAlD
Docetaxel—MAP4—brainstem—meningioma	0.0013	0.0322	CbGeAlD
Docetaxel—MAPT—medulla oblongata—meningioma	0.00115	0.0285	CbGeAlD
Docetaxel—KIF11—brain—meningioma	0.00113	0.028	CbGeAlD
Docetaxel—MAPT—spinal cord—meningioma	0.00103	0.0255	CbGeAlD
Docetaxel—MAP2—brainstem—meningioma	0.00102	0.0253	CbGeAlD
Docetaxel—MAP4—medulla oblongata—meningioma	0.000907	0.0224	CbGeAlD
Docetaxel—MAPT—cerebellum—meningioma	0.000815	0.0202	CbGeAlD
Docetaxel—MAP4—spinal cord—meningioma	0.000808	0.02	CbGeAlD
Docetaxel—TUBB4A—brainstem—meningioma	0.000791	0.0196	CbGeAlD
Docetaxel—TUBB8—brain—meningioma	0.000763	0.0189	CbGeAlD
Docetaxel—MAP2—medulla oblongata—meningioma	0.000714	0.0177	CbGeAlD
Docetaxel—MAPT—brain—meningioma	0.000662	0.0164	CbGeAlD
Docetaxel—MAP4—cerebellum—meningioma	0.000641	0.0159	CbGeAlD
Docetaxel—TUBB3—cerebellum—meningioma	0.000641	0.0159	CbGeAlD
Docetaxel—MAP2—spinal cord—meningioma	0.000637	0.0158	CbGeAlD
Docetaxel—EGFR—cerebellum—meningioma	0.000576	0.0143	CbGeAlD
Docetaxel—TUBB4A—medulla oblongata—meningioma	0.000552	0.0137	CbGeAlD
Docetaxel—TUBB2B—medulla oblongata—meningioma	0.000533	0.0132	CbGeAlD
Docetaxel—TUBB3—brain—meningioma	0.000521	0.0129	CbGeAlD
Docetaxel—MAP4—brain—meningioma	0.000521	0.0129	CbGeAlD
Docetaxel—TUBB1—brain—meningioma	0.000509	0.0126	CbGeAlD
Docetaxel—MAP2—cerebellum—meningioma	0.000505	0.0125	CbGeAlD
Docetaxel—TUBB—medulla oblongata—meningioma	0.000505	0.0125	CbGeAlD
Docetaxel—TUBB2A—medulla oblongata—meningioma	0.000502	0.0124	CbGeAlD
Docetaxel—TUBB6—medulla oblongata—meningioma	0.000495	0.0123	CbGeAlD
Docetaxel—TUBB4A—spinal cord—meningioma	0.000492	0.0122	CbGeAlD
Docetaxel—TUBB2B—spinal cord—meningioma	0.000475	0.0118	CbGeAlD
Docetaxel—BCL2—brain—meningioma	0.000473	0.0117	CbGeAlD
Docetaxel—EGFR—brain—meningioma	0.000468	0.0116	CbGeAlD
Docetaxel—TUBB—spinal cord—meningioma	0.00045	0.0111	CbGeAlD
Docetaxel—TUBB2A—spinal cord—meningioma	0.000448	0.0111	CbGeAlD
Docetaxel—TUBB6—spinal cord—meningioma	0.000441	0.0109	CbGeAlD
Docetaxel—ABCC10—medulla oblongata—meningioma	0.000433	0.0107	CbGeAlD
Docetaxel—TUBB4B—medulla oblongata—meningioma	0.00043	0.0107	CbGeAlD
Docetaxel—MAP2—brain—meningioma	0.00041	0.0102	CbGeAlD
Docetaxel—TUBB4A—cerebellum—meningioma	0.00039	0.00966	CbGeAlD
Docetaxel—ABCC10—spinal cord—meningioma	0.000386	0.00957	CbGeAlD
Docetaxel—TUBB4B—spinal cord—meningioma	0.000384	0.0095	CbGeAlD
Docetaxel—TUBB2B—cerebellum—meningioma	0.000377	0.00933	CbGeAlD
Docetaxel—TUBB—cerebellum—meningioma	0.000357	0.00883	CbGeAlD
Docetaxel—TUBB2A—cerebellum—meningioma	0.000355	0.00879	CbGeAlD
Docetaxel—SLC22A7—brain—meningioma	0.000354	0.00877	CbGeAlD
Docetaxel—TUBB6—cerebellum—meningioma	0.00035	0.00867	CbGeAlD
Docetaxel—TUBB4A—brain—meningioma	0.000317	0.00784	CbGeAlD
Docetaxel—ABCC10—cerebellum—meningioma	0.000306	0.00759	CbGeAlD
Docetaxel—TUBB2B—brain—meningioma	0.000306	0.00758	CbGeAlD
Docetaxel—TUBB4B—cerebellum—meningioma	0.000304	0.00753	CbGeAlD
Docetaxel—TUBB—brain—meningioma	0.00029	0.00717	CbGeAlD
Docetaxel—TUBB2A—brain—meningioma	0.000288	0.00714	CbGeAlD
Docetaxel—TUBB6—brain—meningioma	0.000284	0.00704	CbGeAlD
Docetaxel—ABCG2—medulla oblongata—meningioma	0.000254	0.00628	CbGeAlD
Docetaxel—ABCC10—brain—meningioma	0.000249	0.00616	CbGeAlD
Docetaxel—TUBB4B—brain—meningioma	0.000247	0.00612	CbGeAlD
Docetaxel—CYP1B1—cerebellum—meningioma	0.000241	0.00597	CbGeAlD
Docetaxel—ABCG2—spinal cord—meningioma	0.000226	0.0056	CbGeAlD
Docetaxel—ABCC1—cerebellum—meningioma	0.000217	0.00537	CbGeAlD
Docetaxel—CYP1B1—brain—meningioma	0.000196	0.00485	CbGeAlD
Docetaxel—ABCG2—cerebellum—meningioma	0.000179	0.00444	CbGeAlD
Docetaxel—ABCC1—brain—meningioma	0.000176	0.00436	CbGeAlD
Docetaxel—ABCG2—brain—meningioma	0.000146	0.00361	CbGeAlD
Docetaxel—ABCB1—medulla oblongata—meningioma	0.000125	0.0031	CbGeAlD
Docetaxel—ABCB1—spinal cord—meningioma	0.000112	0.00276	CbGeAlD
Docetaxel—ABCB1—cerebellum—meningioma	8.85e-05	0.00219	CbGeAlD
Docetaxel—EGFR—GAB1 signalosome—ERBB2—meningioma	8.39e-05	0.00164	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—PLAUR—meningioma	8.37e-05	0.00164	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—PLAUR—meningioma	8.37e-05	0.00164	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—PGR—meningioma	8.34e-05	0.00163	CbGpPWpGaD
Docetaxel—EGFR—Constitutive PI3K/AKT Signaling in Cancer—PTEN—meningioma	8.2e-05	0.00161	CbGpPWpGaD
Docetaxel—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB2—meningioma	8.2e-05	0.00161	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—AKT1—meningioma	8.15e-05	0.00159	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—meningioma	8.13e-05	0.00159	CbGpPWpGaD
Docetaxel—EGFR—ErbB Signaling Pathway—TP53—meningioma	8.12e-05	0.00159	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—AKT1—meningioma	8.12e-05	0.00159	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—PLAUR—meningioma	8.08e-05	0.00158	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—TP53—meningioma	8.07e-05	0.00158	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—PDGFB—meningioma	8.06e-05	0.00158	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—PDGFB—meningioma	8.06e-05	0.00158	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—PDGFB—meningioma	8.06e-05	0.00158	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—PDGFB—meningioma	7.98e-05	0.00156	CbGpPWpGaD
Docetaxel—EGFR—Androgen receptor signaling pathway—PTEN—meningioma	7.98e-05	0.00156	CbGpPWpGaD
Docetaxel—EGFR—a6b1 and a6b4 Integrin signaling—AKT1—meningioma	7.94e-05	0.00155	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—PDGFB—meningioma	7.91e-05	0.00155	CbGpPWpGaD
Docetaxel—KIF11—Immune System—ERBB2—meningioma	7.91e-05	0.00155	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—PDGFB—meningioma	7.88e-05	0.00154	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—meningioma	7.83e-05	0.00153	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—PLAUR—meningioma	7.83e-05	0.00153	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—PLAUR—meningioma	7.65e-05	0.0015	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—PDGFB—meningioma	7.61e-05	0.00149	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—AKT1—meningioma	7.61e-05	0.00149	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—meningioma	7.6e-05	0.00149	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HES1—meningioma	7.59e-05	0.00149	CbGpPWpGaD
Docetaxel—BCL2—Corticotropin-releasing hormone—AKT1—meningioma	7.58e-05	0.00148	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—PDGFB—meningioma	7.46e-05	0.00146	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—AKT1—meningioma	7.42e-05	0.00145	CbGpPWpGaD
Docetaxel—EGFR—PI-3K cascade—PTEN—meningioma	7.39e-05	0.00145	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—PTEN—meningioma	7.36e-05	0.00144	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	7.33e-05	0.00143	CbGpPWpGaD
Docetaxel—EGFR—PI3K/AKT activation—PTEN—meningioma	7.21e-05	0.00141	CbGpPWpGaD
Docetaxel—ABCB1—brain—meningioma	7.19e-05	0.00178	CbGeAlD
Docetaxel—EGFR—GAB1 signalosome—PTEN—meningioma	7.16e-05	0.0014	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—PDGFB—meningioma	7.14e-05	0.0014	CbGpPWpGaD
Docetaxel—EGFR—Signaling events mediated by PTP1B—AKT1—meningioma	7.07e-05	0.00138	CbGpPWpGaD
Docetaxel—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—meningioma	6.99e-05	0.00137	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD34—meningioma	6.96e-05	0.00136	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ALAD—meningioma	6.89e-05	0.00135	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—PLAUR—meningioma	6.87e-05	0.00134	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	6.87e-05	0.00134	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—meningioma	6.84e-05	0.00134	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	6.83e-05	0.00134	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD34—meningioma	6.78e-05	0.00133	CbGpPWpGaD
Docetaxel—KIF11—Immune System—PTEN—meningioma	6.75e-05	0.00132	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CTSL—meningioma	6.74e-05	0.00132	CbGpPWpGaD
Docetaxel—EGFR—Thromboxane A2 receptor signaling—AKT1—meningioma	6.66e-05	0.0013	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTSL—meningioma	6.64e-05	0.0013	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—AKT1—meningioma	6.62e-05	0.00129	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—PDGFB—meningioma	6.49e-05	0.00127	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—ERBB2—meningioma	6.48e-05	0.00127	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CTSL—meningioma	6.47e-05	0.00127	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—TP53—meningioma	6.41e-05	0.00126	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—AKT1—meningioma	6.41e-05	0.00125	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—PLAUR—meningioma	6.28e-05	0.00123	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—ERBB2—meningioma	6.2e-05	0.00121	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—ERBB2—meningioma	6.1e-05	0.00119	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AP1B1—meningioma	6.09e-05	0.00119	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—TP53—meningioma	6.04e-05	0.00118	CbGpPWpGaD
Docetaxel—EGFR—LPA receptor mediated events—AKT1—meningioma	5.99e-05	0.00117	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AP1B1—meningioma	5.97e-05	0.00117	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TP53—meningioma	5.91e-05	0.00116	CbGpPWpGaD
Docetaxel—EGFR—AGE/RAGE pathway—AKT1—meningioma	5.84e-05	0.00114	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—ERBB2—meningioma	5.83e-05	0.00114	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—TP53—meningioma	5.82e-05	0.00114	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—ERBB2—meningioma	5.8e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—ERBB2—meningioma	5.8e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—AKT1—meningioma	5.77e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—ERBB2—meningioma	5.77e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—ERBB2—meningioma	5.74e-05	0.00112	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Telomerase—AKT1—meningioma	5.7e-05	0.00112	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—meningioma	5.66e-05	0.00111	CbGpPWpGaD
Docetaxel—EGFR—Disease—AP1B1—meningioma	5.62e-05	0.0011	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—PTEN—meningioma	5.56e-05	0.00109	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—PTEN—meningioma	5.52e-05	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—PDGFB—meningioma	5.49e-05	0.00107	CbGpPWpGaD
Docetaxel—ABCG2—HIF-1-alpha transcription factor network—AKT1—meningioma	5.45e-05	0.00107	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	5.4e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—ERBB2—meningioma	5.4e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—ERBB2—meningioma	5.4e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—ERBB2—meningioma	5.35e-05	0.00105	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—ERBB2—meningioma	5.3e-05	0.00104	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—PDGFB—meningioma	5.29e-05	0.00104	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—PTEN—meningioma	5.29e-05	0.00103	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—ERBB2—meningioma	5.28e-05	0.00103	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—PTEN—meningioma	5.23e-05	0.00102	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—PTEN—meningioma	5.2e-05	0.00102	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—ERBB2—meningioma	5.1e-05	0.000999	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—AKT1—meningioma	5.1e-05	0.000998	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	5.08e-05	0.000995	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—meningioma	5e-05	0.000979	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—ERBB2—meningioma	5e-05	0.000978	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—AKT1—meningioma	4.99e-05	0.000977	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—PTEN—meningioma	4.97e-05	0.000972	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—PTEN—meningioma	4.94e-05	0.000968	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—PTEN—meningioma	4.94e-05	0.000968	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—PTEN—meningioma	4.92e-05	0.000963	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—AKT1—meningioma	4.91e-05	0.000961	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—PTEN—meningioma	4.89e-05	0.000958	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALAD—meningioma	4.87e-05	0.000953	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	4.82e-05	0.000944	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	4.78e-05	0.000936	CbGpPWpGaD
Docetaxel—EGFR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—meningioma	4.73e-05	0.000925	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALAD—meningioma	4.71e-05	0.000922	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—PTEN—meningioma	4.6e-05	0.000901	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	4.6e-05	0.000901	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—PTEN—meningioma	4.6e-05	0.000901	CbGpPWpGaD
Docetaxel—EGFR—Androgen receptor signaling pathway—AKT1—meningioma	4.6e-05	0.0009	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—PTEN—meningioma	4.56e-05	0.000893	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—PTEN—meningioma	4.52e-05	0.000885	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—PTEN—meningioma	4.5e-05	0.000881	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—TSHB—meningioma	4.44e-05	0.000869	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—PTEN—meningioma	4.35e-05	0.000852	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—ERBB2—meningioma	4.35e-05	0.000851	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TP53—meningioma	4.35e-05	0.000851	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	4.33e-05	0.000848	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALAD—meningioma	4.28e-05	0.000839	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—PTEN—meningioma	4.26e-05	0.000834	CbGpPWpGaD
Docetaxel—EGFR—PI-3K cascade—AKT1—meningioma	4.26e-05	0.000834	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALAD—meningioma	4.25e-05	0.000831	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—AKT1—meningioma	4.24e-05	0.00083	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	4.22e-05	0.000827	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—TSHB—meningioma	4.19e-05	0.000819	CbGpPWpGaD
Docetaxel—EGFR—PI3K/AKT activation—AKT1—meningioma	4.16e-05	0.000814	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HES1—meningioma	4.14e-05	0.000811	CbGpPWpGaD
Docetaxel—EGFR—GAB1 signalosome—AKT1—meningioma	4.12e-05	0.000807	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD34—meningioma	4.11e-05	0.000805	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	4.08e-05	0.000798	CbGpPWpGaD
Docetaxel—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	4.03e-05	0.000789	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—AKT1—meningioma	4.03e-05	0.000789	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—AKT1—meningioma	3.98e-05	0.00078	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTSL—meningioma	3.93e-05	0.000768	CbGpPWpGaD
Docetaxel—KIF11—Immune System—AKT1—meningioma	3.89e-05	0.000761	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—meningioma	3.79e-05	0.000742	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—PTEN—meningioma	3.71e-05	0.000726	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—ERBB2—meningioma	3.68e-05	0.00072	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—AKT1—meningioma	3.62e-05	0.000708	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—meningioma	3.57e-05	0.000699	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—SMO—meningioma	3.56e-05	0.000697	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—ERBB2—meningioma	3.55e-05	0.000695	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CST3—meningioma	3.55e-05	0.000695	CbGpPWpGaD
Docetaxel—EGFR—Disease—CST3—meningioma	3.34e-05	0.000655	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—ERBB2—meningioma	3.33e-05	0.000652	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—meningioma	3.28e-05	0.000641	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—AKT1—meningioma	3.18e-05	0.000623	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TSHB—meningioma	3.14e-05	0.000614	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—PTEN—meningioma	3.14e-05	0.000614	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PDGFB—meningioma	3.13e-05	0.000613	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PDGFB—meningioma	3.08e-05	0.000604	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALAD—meningioma	3.07e-05	0.000601	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—AKT1—meningioma	3.05e-05	0.000596	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TSHB—meningioma	3.03e-05	0.000594	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—PTEN—meningioma	3.03e-05	0.000592	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—AKT1—meningioma	3.01e-05	0.00059	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PDGFB—meningioma	3.01e-05	0.000588	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—AKT1—meningioma	3e-05	0.000587	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—meningioma	2.96e-05	0.000579	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	2.95e-05	0.000577	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—AKT1—meningioma	2.86e-05	0.00056	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—AKT1—meningioma	2.85e-05	0.000558	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—AKT1—meningioma	2.85e-05	0.000558	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—AKT1—meningioma	2.83e-05	0.000555	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—AKT1—meningioma	2.82e-05	0.000552	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—meningioma	2.81e-05	0.000549	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	2.78e-05	0.000544	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—AKT1—meningioma	2.77e-05	0.000542	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TSHB—meningioma	2.76e-05	0.00054	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TSHB—meningioma	2.74e-05	0.000536	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—meningioma	2.72e-05	0.000531	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—AKT1—meningioma	2.65e-05	0.000519	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—AKT1—meningioma	2.65e-05	0.000519	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	2.65e-05	0.000519	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—AKT1—meningioma	2.63e-05	0.000515	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—AKT1—meningioma	2.61e-05	0.00051	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—AKT1—meningioma	2.6e-05	0.000508	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	2.56e-05	0.000502	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—meningioma	2.53e-05	0.000495	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—AKT1—meningioma	2.51e-05	0.000491	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	2.5e-05	0.000489	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TSHB—meningioma	2.47e-05	0.000484	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—AKT1—meningioma	2.46e-05	0.000481	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—ERBB2—meningioma	2.38e-05	0.000465	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	2.35e-05	0.00046	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—meningioma	2.32e-05	0.000455	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALAD—meningioma	2.32e-05	0.000453	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	2.19e-05	0.000428	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—AKT1—meningioma	2.14e-05	0.000418	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—meningioma	2.13e-05	0.000416	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SMO—meningioma	2.1e-05	0.000412	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—ERBB2—meningioma	2.1e-05	0.000411	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HES1—meningioma	2.09e-05	0.000409	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ERBB2—meningioma	2.07e-05	0.000405	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PGR—meningioma	2.02e-05	0.000395	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ERBB2—meningioma	2.01e-05	0.000394	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TSHB—meningioma	1.98e-05	0.000387	CbGpPWpGaD
Docetaxel—EGFR—Disease—HES1—meningioma	1.97e-05	0.000385	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTEN—meningioma	1.92e-05	0.000376	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—meningioma	1.86e-05	0.000363	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PDGFB—meningioma	1.82e-05	0.000357	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—AKT1—meningioma	1.81e-05	0.000354	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PTEN—meningioma	1.79e-05	0.00035	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PDGFB—meningioma	1.79e-05	0.00035	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PTEN—meningioma	1.76e-05	0.000345	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—AKT1—meningioma	1.74e-05	0.000341	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PTEN—meningioma	1.72e-05	0.000336	CbGpPWpGaD
Docetaxel—EGFR—Disease—PDGFB—meningioma	1.68e-05	0.000329	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—meningioma	1.61e-05	0.000314	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TSHB—meningioma	1.49e-05	0.000292	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	1.49e-05	0.000292	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALAD—meningioma	1.43e-05	0.000279	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HES1—meningioma	1.38e-05	0.00027	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	1.26e-05	0.000247	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB2—meningioma	1.22e-05	0.000239	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTEN—meningioma	1.21e-05	0.000237	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—meningioma	1.2e-05	0.000234	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PDGFB—meningioma	1.18e-05	0.000231	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—meningioma	1.17e-05	0.000229	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—meningioma	1.13e-05	0.000221	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—meningioma	1.04e-05	0.000204	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—meningioma	1.03e-05	0.000202	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—meningioma	1.02e-05	0.0002	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—meningioma	1.02e-05	0.000199	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—meningioma	9.9e-06	0.000194	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—meningioma	9.62e-06	0.000188	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TSHB—meningioma	9.2e-06	0.00018	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—meningioma	8.55e-06	0.000167	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—meningioma	8.27e-06	0.000162	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—meningioma	7.9e-06	0.000155	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—meningioma	7.52e-06	0.000147	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—meningioma	7.46e-06	0.000146	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—meningioma	6.97e-06	0.000136	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—meningioma	6.74e-06	0.000132	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—meningioma	6.57e-06	0.000129	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—meningioma	6.01e-06	0.000118	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—meningioma	5.88e-06	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—meningioma	5.54e-06	0.000109	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—meningioma	5.39e-06	0.000105	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—meningioma	4.93e-06	9.64e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—meningioma	4.77e-06	9.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—meningioma	4.6e-06	9e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—meningioma	4.34e-06	8.49e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—meningioma	4.3e-06	8.41e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—meningioma	4.07e-06	7.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—meningioma	3.88e-06	7.6e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—meningioma	3.11e-06	6.08e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—meningioma	2.51e-06	4.9e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—meningioma	2.34e-06	4.59e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—meningioma	1.44e-06	2.83e-05	CbGpPWpGaD
